U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Treatment of conduct disorder

Patent 6184222 Issued on February 6, 2001. Estimated Expiration Date: Icon_subject September 17, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

Treatment of lower urinary tract disorders with selective norepinephrine uptake inhibitors
Patent #: 5441985
Issued on: 08/15/1995
Inventor: Foreman

Potentiation of drug response
Patent #: 5532268
Issued on: 07/02/1996
Inventor: Wong, et al.

Treatment of attention-deficit/hyperactivity disorder
Patent #: 5658590
Issued on: 08/19/1997
Inventor: Heiligenstein, et al.

Treatment of attention-deficit/hyperactivity disorder Patent #: 5696168
Issued on: 12/09/1997
Inventor: Heiligenstein, et al.

Inventor

Assignee

Application

No. 156285 filed on 09/17/1998

US Classes:

514/239.2, The chalcogen is bonded directly to two carbon atoms514/238.8, Chalcogen attached indirectly to the morpholine ring by acyclic nonionic bonding514/239.5, Carbocyclic ring attached indirectly to the morpholine ring by nonionic bonding514/438, The hetero ring is five-membered514/620, The nitrogen in R is an amino nitrogen attached indirectly to a ring by acyclic bonding514/649, Amino nitrogen attached to aryl ring or aryl ring system by an acyclic carbon or acyclic chain514/651, Ether oxygen is part of the chain514/653, Hydroxy, bonded directly to carbon, attached directly or indirectly to the acyclic carbon or chain by acyclic nonionic bonding (e.g., beta hydroxy phenethylamines, etc.)514/654The chain consists of two or more carbons which are unsubtituted or have acyclic hydrocarbyl substituents only

Examiners

Primary: Krass, Frederick

Attorney, Agent or Firm

Foreign Patent References

  • 0 687 472 EP. 12/13/1995
  • WO96/12485 WO. 05/13/1996

International Class

A61K 031/535

Abstract

Norepinephrine reuptake inhibitors are used to treat conduct disorder.

Other References

  • Chemical Abstract 89:157222, "Comparison of Inhibition of Monoamine Uptake by Cocaine, Methylphenidate, and Amphetamine", Apr. 1978
  • POPPER, C.W.: "Antidepressants in the treatment of attention-deficit/hyperactivity disorder" THE JOURNAL OF CLINICAL PSYCHIATRY, vol. 58 , No. suppl. 13, 1997, pp. 14-29
  • GREYDANUS, D.E. ET AL.: "The rebellious adolescent: Evaluation and management of oppositional and conduct disorders"PEDIATRIC CLINICS OF NORTH AMERICA, vol. 44, No. 6, pp. 1457-1485 (1997
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$18.95more info
 
Sign InRegister
Username  
Password   
forgot password?